A case report highlights the development of vitiligo and alopecia universalis in a patient with myasthenia gravis after receiving rituximab therapy. This finding may prompt further investigation into the side effects of rituximab in rare disease populations.
case report vitiligo and alopecia universalis following rituximab therapy in a patient with myasthenia gravis
Original title: “Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis.”